ECULIZUMAB

eculizumab 300 mg/30 mL injection, 30 mL vial

ECULIZUMAB (10190H)

eculizumab 300 mg/30 mL injection, 30 mL vial
10190H
Body System:
Manner of administration:Injection
Public
S100 HSD Public
Authority Required

Restriction

Indication: Atypical haemolytic uraemic syndrome (aHUS)
Treatment phase: Initial treatment - Balance of Supply

Restriction

Indication: Atypical haemolytic uraemic syndrome (aHUS)
Treatment phase: Recommencement - Balance of Supply
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 4 DPMQ: $5,358.60 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Soliris